October 4, 2024
"Direct cellular reprogramming in cancer and for therapy: The Good, the Bad, and the Ugly"
Tushar Desai, MD, MPH
Professor of Medicine,
Director, Graduate Studies, Institute for Stem Cell Biology and Regenerative Medicine,
Director, Translational Lung Biology, Department of Medicine
Stanford University School of Medicine